James Mackaness - May 26, 2023 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role: Chief Financial Officer
Signature: /s/ James Mackaness
Stock symbol: SLNO
Transactions as of: May 26, 2023
Transactions value $: $0
Form type: 4
Date filed: 5/26/2023, 06:28 PM
Previous filing: May 10, 2023
Next filing: Dec 13, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SLNO	Common Stock	Award	$0	+29.1K	+648.33%	$0.00	33.6K	May 26, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SLNO	Employee stock option (right to buy)	Award	$0	+87.3K		$0.00	87.3K	May 26, 2023	Common Stock	87.3K	$5.25	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest on November 26, 2023, subject to the Reporting Person continuing to be a Service Provider through such date.
F2	Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
F3	One thirty-sixth of the shares subject to the Option shall vest on June 26, 2023 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date.